0.3384
price up icon2.39%   0.0079
after-market Dopo l'orario di chiusura: .35 0.0116 +3.43%
loading
Precedente Chiudi:
$0.3305
Aprire:
$0.3262
Volume 24 ore:
283.19K
Relative Volume:
0.49
Capitalizzazione di mercato:
$22.83M
Reddito:
$391.70K
Utile/perdita netta:
$-52.34M
Rapporto P/E:
-0.4512
EPS:
-0.75
Flusso di cassa netto:
$-45.92M
1 W Prestazione:
-1.34%
1M Prestazione:
+13.29%
6M Prestazione:
-64.89%
1 anno Prestazione:
-54.98%
Intervallo 1D:
Value
$0.326
$0.3412
Intervallo di 1 settimana:
Value
$0.3001
$0.3495
Portata 52W:
Value
$0.2425
$1.47

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
Nome
Ovid Therapeutics Inc
Name
Telefono
212-776-4381
Name
Indirizzo
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
Dipendente
23
Name
Cinguettio
@OvidRx
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
OVID's Discussions on Twitter

Confronta OVID con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OVID
Ovid Therapeutics Inc
0.3384 22.83M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-18 Downgrade Oppenheimer Outperform → Perform
2024-04-30 Iniziato B. Riley Securities Buy
2024-04-29 Iniziato H.C. Wainwright Buy
2024-04-05 Iniziato Wedbush Outperform
2023-12-21 Iniziato BTIG Research Buy
2023-10-13 Iniziato Oppenheimer Outperform
2021-04-20 Downgrade Cantor Fitzgerald Buy → Neutral
2021-03-03 Downgrade RBC Capital Mkts Outperform → Sector Perform
2020-12-02 Downgrade Citigroup Buy → Neutral
2020-12-02 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 Iniziato RBC Capital Mkts Outperform
2018-04-20 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Ovid Therapeutics Inc Borsa (OVID) Ultime notizie

pulisher
Jun 17, 2025

Balance Sheet Insights: Ovid Therapeutics Inc (OVID)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Jun 17, 2025
pulisher
Jun 13, 2025

Ovid Therapeutics Inc (OVID) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

Rising Leaders 2025: Ovid’s Meg Alexander On Neurology’s Next Frontier - insights.citeline.com

Jun 13, 2025
pulisher
Jun 12, 2025

Transcript : Ovid Therapeutics Inc.Special Call - marketscreener.com

Jun 12, 2025
pulisher
Jun 11, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - mx.advfn.com

Jun 09, 2025
pulisher
Jun 05, 2025

Ovid Therapeutics (OVID) to Showcase Biomarker Advances in Epile - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 | OVID Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Harvard Expert to Present Breakthrough Epilepsy Treatment Data at Ovid Therapeutics Event - Stock Titan

Jun 05, 2025
pulisher
Jun 01, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 01, 2025
pulisher
May 30, 2025

HC Wainwright Predicts Weaker Earnings for Ovid Therapeutics - Defense World

May 30, 2025
pulisher
May 28, 2025

Ovid Therapeutics (NASDAQ:OVID) Price Target Cut to $1.50 by Analysts at HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

Ovid Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025
pulisher
May 27, 2025

Ovid Therapeutics (OVID): HC Wainwright & Co. Lowers Price Targe - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growt - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growth Prospects | OVID Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright cuts Ovid stock price target to $1.50, keeps buy rating - Investing.com

May 27, 2025
pulisher
May 20, 2025

Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) PT at $3.03 - Defense World

May 20, 2025
pulisher
May 19, 2025

What is B. Riley’s Forecast for OVID Q2 Earnings? - Defense World

May 19, 2025
pulisher
May 18, 2025

Q3 EPS Estimate for Ovid Therapeutics Raised by Analyst - Defense World

May 18, 2025
pulisher
May 17, 2025

Wedbush Decreases Earnings Estimates for Ovid Therapeutics - Defense World

May 17, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Ovid Therapeutics (OVID) - The Globe and Mail

May 16, 2025
pulisher
May 13, 2025

Ovid Therapeutics (OVID) Exceeds Q1 Revenue Expectations and Adv - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics (OVID) Reports $43 Million in Cash Reserves | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 202 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics Inc Reports Q1 2025 EPS of -$0.14, Meeting Est - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results | OVID Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics (OVID) Reports $43 Million in Cash Reserves | OVID Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 11, 2025

Ovid Therapeutics (OVID) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Purchased by Renaissance Technologies LLC - Defense World

May 08, 2025
pulisher
May 06, 2025

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 06, 2025
pulisher
May 05, 2025

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results - ADVFN

May 05, 2025
pulisher
May 05, 2025

Dup15q syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 05, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Decreases Stock Holdings in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World

Apr 27, 2025
pulisher
Apr 27, 2025

Ovid Therapeutics (NASDAQ:OVID) Upgraded at William Blair - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Analysts Set Ovid Therapeutics Inc. (NASDAQ:OVID) Target Price at $3.03 - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Ovid Therapeutics Inc [OVID] stock for 2,956 USD was sold by ALEXANDER MARGARET A. - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

The OVID Stock Puzzle: Unraveling Ovid Therapeutics Inc’s Fluctuating Performance - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

A closer look at Ovid Therapeutics Inc (OVID) is warranted - uspostnews.com

Apr 24, 2025
pulisher
Apr 20, 2025

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium | Libero Quotidiano.it - Libero Quotidiano

Apr 20, 2025
pulisher
Apr 18, 2025

Dravet Syndrome Treatment Market Future Business - openPR.com

Apr 18, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025
pulisher
Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 - Investing.com

Apr 07, 2025

Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ovid Therapeutics Inc Azioni (OVID) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Rona Jeffrey A
CBFO
Feb 26 '25
Sale
0.56
3,902
2,185
67,973
ALEXANDER MARGARET A.
President and COO
Jan 27 '25
Buy
0.73
6,810
4,971
34,935
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):